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ABSTRACT 
Objectives: The study was carried out to evaluate the risk fac- 
tors associated with chronic hepatitis C virus (HC\/j infection. 
Methods: This case-control study used multiple logistic regres- 
sion analysis to determine risk factors associated with HCV 
infection. Study participants were followed at 10 liver or gastro- 
enterologic units and included 294 subjects with chronic HCV 
infection and 295 age and sex matched anti-HCV-negative 
controls. 
Results: The use of glass syringes and surgical procedures 
was reported by as many as 77.6% and 73.8% of cases, 
respectively; blood transfusion was recorded in nearly a quar- 
ter of cases; 10.2% of cases, but none of the controls, reported 
past or current intravenous drug use. Multiple logistic regres- 
sion analysis showed that blood transfusion, beinfj the sexual 
partner of an intravenous drug user, and surgery all were inde- 
pendent predictors of the likelihood of HCV infection. 
Conclusions: These findings indicate that, besides the well- 
known sources of infection, such as blood transfusion and 
intravenous drug use, surgical procedures may play an impor- 
tant role in the spread of HCV infection in Italy. Given that a large 
proportion of the general population undergoes surgery, a 
rational and relatively inexpensive policy for the prevention of 
HCV infection must focus on implementing efficient procedures 
for the sterilization of instruments and the use of disposable 
materials in surgical units. 
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Hepatitis C virus (HCV) infection is the main cause of 
chronic liver disease and hepatocellular carcinoma in 
Italy.‘-* The reasons for the wide spread of the infection 
largely are unknown. In general, a classic parenteral expo- 
sure, such as blood transfusion or drug addiction, may be 
recognized in only a minority of cases.lJ Other modes of 
transmission, such as sexual or inapparent parenteral 
routes, have been examined in different studies, but the 
results to date have been inconclusive; vertical transmis- 
sion plays a small role in immunocompetent mothers.5-7 
These results contrast with those obtained in the 
United States, where a definite risk may be identified in 
50 to 60% of cases of chronic HCV infection.’ Recently, 
a case-control study performed in northern Italy showed 
that, besides blood transfusion and drug addiction, pre- 
vious use of nondisposable needles, hospitalization before 
1970, and previous tuberculosis all were independent 
predictors of HCV positivity9 These findings indicate that, 
during the past few decades in Italy, the risk of acquiring 
HCV infection has been multifaceted. 
This multicenter case-control study evaluates the risk 
factors associated to chronic HCV infection in patients 
from various areas in Italy, 
STUDY POPULATION AND METHODS 
Ten Italian centers for liver diseases and gastroenterol- 
ogy participated in the study. Cases were consecutive 
inpatients or outpatients referred to the hospital because 
of anti-HCV antibodies in serum. Controls were consec- 
utive anti-HCV-negative subjects observed in the same 
center, and were age and sex matched with cases. Con- 
trols were subjects suffering from gallstones, inflamma- 
tory bowel diseases, gastric or duodenal ulcer, gastric 
cancer, cancer of the colon, or diverticulosis. Excluded 
from both cases and controls were hepatitis B surface 
antigen (HBsAg) or anti-human immunodeficiency virus 
(HIV)-positive patients, hemophiliacs, and thalassemics. 
To ensure that both the cases and the controls were 
exposed to the same selection biases, if any, the authors 
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checked that they lived in the same area, were referred 
to the hospital through the same channels (generally, 
request by the general practitioner), and were seen in 
the same unit. They were interviewed using a standard 
questionnaire on their admission to the hospital about 
their sociodemographic characteristics and potential risk 
factors. Only major surgery (i.e., abdominal and chest 
surgery, orthopedic and otolaryngeal surgery, etc.) was 
considered as a potential risk factor. Control patients were 
rejected only if they did not fit the predetermined crite- 
ria. The study period was January to December 1995. 
The presence of anti-HCV antibodies was checked 
in all patients by second generation enzyme-linked 
immunosorbent assay (ELISA) (Ortho Diagnostics, Rari- 
tan, NJ) and confirmed by recombinant immunoblot assay 
(RIBA); ELISA determined HBsAg and anti-HIV positivity. 
The crude odds ratios (OR), which are estimates of 
the relative risk linking anti-HCV seropositivity to poten- 
tial risk factors, were estimated by univariate analysis. To 
identify the variables independently associated to HCV 
infection, the adjusted OR were estimated by multiple 
logistic regression analysis.lo,ll 
RESULTS 
Two hundred and ninety-four cases and 295 controls 
were recruited. Of the cases, 30 (10.2%) had normal ala- 
nine aminotransferase (ALT) levels, 212 (72.1%) had 
biopsy-proven chronic hepatitis, 47 (16.0%) had liver cir- 
rhosis, and 3 (1.0%) had hepatocellular carcinoma. The 
main sociodemographic characteristics of the cases and 
controls are reported in Table 1. The groups were 
matched for age and sex; moreover, no differences were 
observed for place of birth, educational level, or number 
of subjects in the household. 
The frequencies of risk factors reported by cases and 
controls and the crude odds ratio linking HCV positivity 
to the various exposures are shown in Table 2. The use 
of glass syringes and past surgery were reported by as 
many as 77.6% and 73.8% of cases, respectively; blood 
transfusion was reported by nearly a quarter of cases; 
Table 1. Sociodemographic Characteristics of Subjects 
Parameter 
Age (y) median (range) 
Male (%) 
Place of birth 
North (%) 
South (%) 
Education 
Primary school (%) 
Junior high school (%) 
High school/university 
Subjects in household 
<4 
>4 
Cases Controls 
(n = 294) (n = 295) 
50 (15-78) 50 (14-77) 
147 (50.0) 148 (50.2) 
130 (44.2) 154 (52.2) 
164 (55.8) 141 (47.8) 
119 (40.5) 106 (35.9) 
94 (32.0) 87 (29.5) 
81 (27.5) 102 (34.6) 
245 (83.3) 241 (81.7) 
49 (16.7) 54 (18.3) 
Table 2. Frequency of Risk Factors Reported by 
HCV-Positive Cases and HCV-Negative Controls 
Risk Factor Cases(%) Controls 1%) OR* 95% cl+ 
Blood transfusion 26.2 9.0 3.6 2.2-5.8 
Surgical procedures 73.8 58.3 2.02 1.42-2.86 
Use of glass syringes 77.6 68.3 1.6 1 .I-2.3 
Sexual partner of 
drug addict 
Health care 
6.3 1.4 4.8 1.6-l 4.5 
employment 5.4 13.6 
Intravenous drug use 10.2 0 
*Crude odds ratios derived from univariate analysis. 
195% confidence intervals. 
0.38 0.20-0.69 
10.2% of the cases but none of the controls stated past 
or current intravenous drug use. A positive association 
was found to link anti-HCV positivity with all the sources 
of infection considered, except health care employment. 
Since none of the controls reported intravenous drug 
use, odds ratio was not calculated for this association, 
which would obviously be strong, as 10.2% of cases 
reported this exposure. 
When each risk factor was adjusted for the con- 
founding effects of all the others and for age, sex, and 
educational level in a multiple logistic regression analy- 
sis (Table 3), blood transfusion, being a sexual partner of 
a drug abuser, and surgical procedures all were noted to 
be independent predictors of the likelihood of HCV infec- 
tion. Originating from southern Italy and the use of glass 
syringes were unassociated factors. 
DISCUSSION 
The aim of this study was to assess the risk factors asso- 
ciated to HCV infection in chronic anti-HCV-positive sub- 
jects, since an overt parenteral exposure is identified in 
only a limited number of cases. 
Since comparability is essential in studies on risk fac- 
tors, cases and controls were enrolled who lived in the 
same area, were referred to the hospitals through similar 
channels, and were matched according to their status as 
in- or outpatient. This ensured that subjects in both cat- 
egories were exposed to similar selection bias, if any. 
Moreover, the broad diagnostic representation of non- 
hepatic gastrointestinal diseases in control subjects pos- 
sibly prevented any control selection bias. 
Table 3. Risk Factors Associated to HCV Infection 
Risk Factors OR* 95% CI 
Region of birth 1.45 0.97-2.17 
Transfusion 2.91 1.65-5.14 
Surgical procedures 2.18 1.42-3.35 
Use of glass syringe 1.23 0.77-l .96 
Partner of IV drug user 5.53 1.44-21.3 
*Adjusted OR derived from multiple logistic regression; each risk factor was 
adjusted for the confounding effects of all other listed variables and for age, sex, 
and educational level of the subjects. 
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The results of this case-control study emphasize that, 
besides the well-known sources of infection (e.g., blood 
transfusion and intravenous drug abuse), surgery and 
being the sexual partner of a drug addict have played an 
important role in the spread of HCV infection in Italy As 
expected, blood transfusion and intravenous drug use 
emerged as the main risk factors for chronic HCV infec- 
tion. In Italy, as in most developed countries, blood donors 
have been screened for anti-HCV since 1990. The use of 
the second generation ELISA test in the detection of anti- 
HCV since 1992 has further increased screening efficacy 
As a consequence, the incidence rate of transfusion-asso- 
ciated hepatitis C has dramatically decreased in Italy from 
4.4 cases per l,OOO,OOO inhabitants in 1989 to 0.4 cases 
in 1993.‘* Thus, the risk of post-transfusion hepatitis C in 
Italy is now negligible. 
Also, being a health care worker is not associated 
with any increase in the risk of HCV infection in the set- 
ting investigated. Indeed, counselling on the protection 
of health care workers against parenterally transmitted 
viruses has been ongoing in Italy since the early eighties, 
because hepatitis B virus infection was highly endemic 
at that time. Soon after, the spread of HIV infection re- 
inforced the preventive measures and led to a further 
beneficial effect on HCV infection. 
Intravenous drug use was reported by 10.2% of the 
cases and by none of the controls. Although the risk of 
HCV infection associated with intravenous drug use is 
high, few of the HCV infections occurring in Italy can be 
attributed to intravenous drug use, which is low in the 
general Italian population. 
Surgical procedures proved to be an independent 
predictor of HCV infection in this study. A possible role 
of surgery in transmitting non-A, non-B (NANB) hepatitis 
was shown some years ago by a retrospective analysis of 
acute hepatitis cases in Italy l3 This finding was confirmed 
by the results of a recent case-control study on subjects 
with acute NANB hepatitis,‘* which showed that a sur- 
gical procedure within 6 months preceding the onset of 
the disease was strongly associated (OR = 12.0; 95% CI 
= 4.0-35.0) with acute hepatitis C. Since a large propor- 
tion of the general population undergoes surgery, the 
results underscore the importance of correctly applying 
the procedures for sterilizing surgical instruments and 
the use of disposable materials, particularly in those emer- 
gency units where the high turnover of patients may fur- 
ther enhance the risk of HCV infection. 
In this study, data showed that being a sexual partner 
of an intravenous drug addict represents an independent 
risk factor for acquiring HCV infection. In general, the data 
assessing the sexual risk in the transmission of HCV infec- 
tion are contradictory. 15-i8 A study on community-acquired 
acute NANB hepatitis showed that patients with no his- 
tory of parenteral exposure proved to have 11 times as 
many sexual partners as the controls.* In this study, which 
refers to patients exposed to the virus several years ear- 
lier, the lifetime number of sexual partners could provide 
a biased estimate of the true association linking HCV infec- 
tion to sexual activity. Moreover, it may be expected that 
some sexual partners of intravenous drug users might 
have experienced occasional parenteral drug use that they 
did not admit at the interview. 
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